Published in Lab Business Week, June 11th, 2006
Study 1: A recent study from the United States has reported that G-quartet oligonucleotides target transduction and transcription in head and neck cancer.
"Signal transducer and activator of transcription 3 (Stat3) is a critical mediator of oncogenic signaling activated frequently in many types of human cancer where it contributes to tumor cell growth and resistance to apoptosis. Stat3 has been proposed as a promising target for anticancer drug discovery," wrote N.J. Jing and colleagues, Baylor College of Medicine.
"Recently, we developed a series of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-06-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.